This category will be the broadest, including articles describing new therapies for
mesothelioma cancer, comparing various types of therapies and discussing the outcomes following therapy. The most important aspects of the studies which will be highlighted in the commentary shall be: the type of patients analyzed, the form of therapy used and the outcome pursued by the investigators.
Need synopsis. -
Expert Rev Respir Med. 2010 Jun;4(3):363-72.Dr.
David Sugarbaker, M.D. has provided us with a list of commonly asked questions about
extrapleural pneumonectomy.
Recent
clinical trials report encouraging results in selected patients with
peritoneal mesothelioma (PM) treated with cytoreductive surgery (CRS) and intraperitoneal hyperthermic perfusion (IPHP). -
Ann Surg Oncol. 2007 Feb;14(2):500-8. Epub 2005 Apr 14.Current imaging modalities fail to define precisely the extent of disease in MPM and are inaccurate in selecting patients for treatment. -
Lung Cancer. 2005 Jul;49 Suppl 1:S27-32. Epub 2005 Apr 14.A study to determine the factors influencing the response to palliative radiotherapy 9RT) in
malignant mesothelioma of the pleura (MM). -
Int J Radiat Oncol Biol Phys 1999 Feb 1;43(3):511-6The authors conducted a Phase II trial in which two drugs (etoposide and 5-fluorouracil) were added to the Cancer and Leukemia Group B cisplatin-mitomycin regimen in an effort to define a more effective chemotherapy. -
Cancer 1999 Apr 15;85(8):1740-9This paper reviews the available literature on the systemic drug therapy of MPM. -
Monaldi Arch Chest Dis 1998 Apr;53(2):236-40A case presentation performed during the Grand Rounds at the Froedtert Hospital on the Management of Mesothelioma discusses the neoadjuvant chemotherapy approach followed by resection and radiation.
Other Drugs
Cisplatin is a chemotherapy drug that was approved by the Federal Drug Administration (FDA) in 1978 and is used to treat patients suffering from malignant pleural mesothelioma.
An expanded access program (EAP) provided patient access to pemetrexed prior to its commercial availability. -
Lung Cancer. 2007 Feb;55(2):187-94The current review will cover the dramatic improvements in the treatment of this rare disease that have been recently achieved, as well as the promise that new, molecular-targeted therapies, such as bortezomid, mTOR inhibitors, and Met inhibitors, seem to offer for the next few years. -
Semin Oncol. 2005 Jun;32(3):336-50Pemetrexed is a novel antifolate that inhibits several folate-dependent enzymes in addition to thymidylate synthase. Such a drug may have theoretical advantages over fluoropyrimidines and specifically acting antifolates. -
Semin Oncol 2002 Apr;29(2 Suppl 5):54-61Alimta®, a new type of cancer treatment being developed by Eli Lilly, is the first treatment to significantly improve
mesothelioma prognosis and ameliorate the symptoms of the disease. -
Financial Times 2002 MayRecombinant human interferon gamma (r-hu-IFNgamma) exerts both antitumoral activity in the early stages of human malignant
mesothelioma and a cytostatic effect in human mesothelioma (HM) cell lines in vitro. -
Oncogene 2001 Mar 1;20(9):1085-93The CALGB conducted a phase II multicenter trial to evaluate the activity of
gemcitabine in malignant mesothelioma (CALGB protocol 9530). -
Lung Cancer 2000 Feb-Mar 31(2-3):311-7Researchers at the Newcastle Freeman Hospital have seen rapid improvements in the symptoms of mesothelioma sufferers taking the breakthrough new drug, Alimta®.-
Scotsman 2000 Nov 7;6Gemcitabine has shown activity in patients with less chemosensitive solid tumors. Phase II screening of novel drugs is an accepted method with which to investigate new therapies in malignant mesothelioma. -
Cancer 1999 Jun 15;85(12):2577-82Researchers at the Veterans Affairs Medical Center and the Department of Medicine at the University of Minnesota may have discovered an effective treatment for mesothelioma using a common cholesterol reducing drug.
Dr. Roman Perez-Soler, Associate Director for Clinical Oncology and Translational Research at the Kaplan Comprehensive Cancer Center, discusses a promising new therapeutic option for patients with malignant
pleural mesothelioma.
Gene Therapy
Mesothelioma may be particularly well suited for
gene therapy treatment owing to its accessibility, allowing both intrapleural and intratumoral gene delivery. -
Cancer Gene Ther. 2006 Oct;13(10):897-904. Epub 2006 Jan 27.As the incidence of this disease has yet to peak, there is a pressing need for new therapeutic approaches. One such approach is gene therapy. -
Expert Opin Biol Ther. 2005 Aug;5(8):1039-49.Several clinical studies have demonstrated objective antitumoral responses to intrapleural interleukin-2 (IL-2) administration in the treatment of malignant pleurisy. -
Cancer 1998 Nov 15;83(10):2099-104This article further explains what mesothelioma is, and mentions gene therapy as a method by which to cure it. Included is contact information for Dr. Joseph A. Treat conducting gene therapy research at the University of Pennsylvania Department of Medicine.
This article discusses the theory behind genes that would attack harmful cancer cells while leaving normal healthy cells alone.
Please see the latest gene therapy treatment study headed by Dr. Paul Schwarzenberger from the LSU Medical Center and Stanley S. Scott Cancer Center.
Investigators at the
University of Pennsylvania Cancer Center have been awarded a Program Project grant from the
National Cancer Institute that will help fund a novel gene therapy trial to treat patients with mesothelioma, a cancer frequently linked to
asbestos exposure.
Photodynamic Therapy
Photodynamic therapy is one of the most promising new fields of medicine for the treatment of diseases and disorders of tissues. It is safe and non-invasive. Explanations of the procedure and a scientific study are provided here.
The National Cancer Institute provides an easy-to-understand discussion of the development of PDT and its
pros and cons.
The LumaCare™ site provides an abstract and details of a recent study entitled
"Photodynamic Therapy of Malignant Mesothelioma of Pleura". The study was conducted at the Norwegian Radium Hospital.
Immunotherapy
Intralesional infusion of cytokines is feasible but can be associated with systemic toxicity and has considerable technical problems. It produces a localized immune reaction with tumor regression in a minority of patients. -
J Immunother 1998 Sep;21(5):389-98Multimodality Therapy
Need synopsis. -
Ann Thorac Surg. 2009 Sep;88(3):870-5; discussion 876.Need synopsis. -
J Clin Oncol. 2009 Jun 20;27(18):3007-13. Epub 2009 Apr 13.Even though followed by a prolonged survival in highly selected patients, the promising results of Sugarbaker's trimodality treatment for malignant pleural mesothelioma (MPM) are debated and not yet uniformly replicated. -
J Cardiovasc Surg (Torino). 2006 Oct;47(5):595-601We reviewed our experience with trimodality management of malignant pleural mesothelioma (MPM). -
Eur J Cardiothorac Surg. 2001 Mar;19(3):346-50.The objective of the study was presentation of the use of pleuropneumonectomy in a multimodality treatment setting and the results. -
Chest 1999 Dec;116(3 Suppl):450S-454SThis study was planned to investigate the feasibility, safety, and pharmacokinetics of a
multimodality therapy including an operation, pleural space perfusion (60 minutes) with cisplatin (100 mg/m2), hyperthermia (41.5 degrees C), and postoperative radiotherapy (55 Gy to chest wall incisions). -
J Thorac Cardiovasc 1999 Apr;117(4):759-65
Before I plunge into telling you what this blog post is about, let me say I’m just really honoured to be writing today and being a part o...
Showing off a cool ombre hairstyle, Canadian model Daria Werbowy stars in the November 27th issue of L’Express Styles. The stunner poses for...
Photographer Daniel Gurton and stylist Emily Stanley team up for this black and white fashion shoot. New face Charlee Fraser wears a minimal...
Inspired by an opulent garden, the spring 2015 lineup of wedding dresses from bridal brand BHLDN is in full bloom. From pretty floral motifs...
Late last year, we posted backstage images of Donna Karan’s spring 2015 campaign star as a guess who. Now, the wait is over with Andreea Dia...
The January-February cover shoot of Vogue Netherlands puts the spotlight on party dressing with a mix of glam and grunge style worn by Crist...
Amphibious warships, also known as “gator freighters”, are part of the U.S. Naval fleet. They are oceangoing ships designed to discharge gro...
Continuing her collaboration with lingerie brand Passionata, Bar Refaeli is back again as the face of its spring-summer 2014 campaign where ...
Taking a look at fall fashions, Free People has launched a new magazine-catalogue which features top models in their latest designs. Martha ...
Model Nikki shows off her seductive side in this fashion spread featured in the winter issue of Schon Magazine. In front of Federica Putelli...
No comments:
Post a Comment